US Patent:
20110256101, Oct 20, 2011
Inventors:
Roger J. Hajjar - Tenafly NJ, US
Yoshiaki Kawase - New York NY, US
Dennis Ladage - New York NY, US
Krisztina Zsebo - La Jolla CA, US
Assignee:
Mount Sinai School of Medicine - New York NY
Celladon Corporation - La Jolla CA
International Classification:
A61K 35/76
A61P 11/00
Abstract:
The present invention provides methods for treating pulmonary hypertension in a subject by delivering a therapeutic adeno-associated virus (AAV)-SERCA2 composition to a subject in need thereof.